A British company is conducting landmark trials which could see medicines derived from or inspired by the cannabis plant itself making their way to American pharmacy shelves
A British company is conducting landmark trials which could see medicines derived from or inspired by the cannabis plant itself making their way to American pharmacy shelves.
GW Pharma is in advanced clinical trials for the world's first pharmaceutical developed from raw marijuana instead of synthetic equivalentsu00a0-- a mouth spray it hopes to market in the US as a treatment for cancer pain.
u00a0
The firm hopes to receive US government approval by the end of next year.
The trials come a quarter of a century after the US Food and Drug Administration (FDA) approved the first prescription drugs based on the main psychoactive ingredient in marijuana.
Sativex contains marijuana's two best known componentsu00a0-- delta 9-THC and cannabidiolu00a0-- and has already been approved in Canada, New Zealand and eight European countries for relieving muscle spasms associated with multiple sclerosis.
FDA approval would represent an important milestone in the United States' often uneasy relationship with marijuana.
ADVERTISEMENT
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
